Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients

P Volteas, P Drakos, LN Alkadaa, NA Cleri… - Journal of Vascular …, 2022 - Elsevier
… This is a single-center retrospective analysis of critically ill intubated patients with COVID-19,
comparing low-molecular-weight heparin (LMWH) and unfractionated heparin (UFH) at …

[HTML][HTML] Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients

C Pawlowski, AJ Venkatakrishnan, C Kirkup… - …, 2021 - thelancet.com
unfractionated Heparin for the treatment of hospitalized patients with COVID-19. We find
that COVID-19 patients administered unfractionated Heparin but not Enoxaparin have higher …

[HTML][HTML] Monitoring of unfractionated heparin in severe COVID-19: an observational study of patients on CRRT and ECMO

AS Streng, TSR Delnoij, MMG Mulder, JWEM Sels… - TH Open, 2020 - thieme-connect.com
… Objective Severe cases of coronavirus disease 2019 (COVID-19Unfractionated
heparin (UFH) to prevent circuit clotting is mandatory but monitoring is complicated by (pseudo)-heparin

Inhaled nebulised unfractionated heparin for the treatment of hospitalised patients with COVID19: A multicentre case series of 98 patients

FMP van Haren, LM van Loon, A Steins… - British Journal of …, 2022 - Wiley Online Library
… admitted to hospital for COVID-19 develop acute respiratory … The pathophysiology of COVID-19
associated lung injury is … unfractionated heparin (UFH) as a treatment for COVID-19. UFH …

[HTML][HTML] Comparison of the effect of unfractionated heparin and enoxaparin sodium at different doses on the course of COVID-19-associated coagulopathy

O Oliynyk, W Barg, A Slifirczyk, Y Oliynyk, S Dubrov… - Life, 2021 - mdpi.com
… use of unfractionated heparin in the treatment of COVID-19-… the advantage of unfractionated
heparin over enoxaparin in … of bleeding complications with unfractionated heparin is not …

[HTML][HTML] Management of therapeutic unfractionated heparin in COVID19 patients: A retrospective cohort study

LD Weeks, KW Sylvester, JM Connors… - Research and Practice in …, 2021 - Elsevier
… who were COVID19 positive and patients who were COVID19heparin monitoring for
patients in our cohort by COVID19 … % for COVID19 positive and 53.1% for COVID19 positive, …

Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre …

F Cools, S Virdone, J Sawhney, RD Lopes… - The Lancet …, 2022 - thelancet.com
… Initial exclusion criteria comprised contraindication to unfractionated heparin or low-molecular-weight
heparin; recent (<48 h) or planned spinal or epidural anaesthesia or puncture; …

Heparin as a therapy for COVID-19: current evidence and future possibilities

JA Hippensteel, WB LaRiviere… - … of Physiology-Lung …, 2020 - journals.physiology.org
Unfractionated heparin is composed of HS chains that are >30 saccharides in length, …
Another group observed that initiation of heparin for 27 patients infected with COVID-19 improved …

[HTML][HTML] The versatile heparin in COVID19

J Thachil - Journal of Thrombosis and Haemostasis, 2020 - jthjournal.org
… In summary, there are several ways heparin can prove beneficial in patients with COVID19
(Figure 1). In this respect, the correct dose of LMWH is a matter of immediate interest as a …

A new challenge of unfractionated heparin anticoagulation treatment for moderate to severe COVID-19 in Japan

R Sato, M Ishikane, N Kinoshita, T Suzuki… - Global Health & …, 2020 - jstage.jst.go.jp
… ) patients during the COVID-19 pandemic. We herein suggest an algorithm for … unfractionated
heparin in moderate to severe COVID-19 cases in Japan, and report a case of COVID-19